RightFit
RecruitingNot applicable

Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps

Multilevel Health System Intervention to Increase Guideline-Concordant Surveillance Colonoscopy for High Risk Colon Polyps

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
21 Years and older
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Interviews, Phone or video check-ins

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "OUTLINE: AIM 1: Participants complete an interview over 20-30 minutes."
  • "Patients receive a reminder 6 months in advance via their patient portal and mail to schedule a colonoscopy, and also receive a phone call from the patient communication center."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests a program to help people with high-risk colon polyps get repeat colonoscopies on time. Polyps are growths in the colon that may turn into cancer. The program works with clinics, care providers, and patients.

This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Part 1 patients: Ages 45 to 75, with high-risk colon or rectal polyps found in the past 5 years.
  • Part 1 includes 12 patients who had a follow-up colonoscopy and 12 who did not. A colonoscopy is a test that looks inside the colon.
  • Part 1 providers: Primary care providers and doctors who treat digestive problems.
  • Part 1 administrators: Staff involved in colon cancer screening, follow-up care for high-risk polyps, or scheduling colonoscopies.
  • Part 2 patients: Ages 45 to 75, with high-risk colon or rectal polyps found during the study’s set two-year period.

Who can't join

  • Part 2: A history of cancer in the colon or rectum.
  • Part 2: Inflammatory bowel disease, such as Crohn’s disease or ulcerative colitis, which cause swelling in the digestive tract.
  • Part 2: Polyposis syndrome, a condition that causes many polyps.
  • Part 2: High-risk polyps cannot be confirmed by a person reviewing medical records.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * AIM 1 PATIENTS: Patients between age 45 and 75 with a HRN diagnosis in the past 5 years * AIM 1 PATIENTS: 12 patients who did and 12 patients who did not have surveillance colonoscopy * AIM 1 PROVIDERS: Primary care providers (PCPs) and gastroenterologists (GIs) * AIM 1 ADMINISTRATORS: Administrators who are involved in care processes related to CRC screening, HRN surveillance, and/or colonoscopy scheduling * AIM 2: Patients age 45 to 75 diagnosed with a HRN during the pre-specified two-year HRN diagnosis period Exclusion Criteria: * AIM 2: Individuals with a personal history of colorectal carcinoma (CRC), inflammatory bowel disease (Crohn's, ulcerative colitis), or polyposis syndrome * AIM 2: HRN cases not confirmed by chart review (human-in-the-loop)

Study sites (1)

CA